BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10503801)

  • 1. Worst-rank score analysis with informatively missing observations in clinical trials.
    Lachin JM
    Control Clin Trials; 1999 Oct; 20(5):408-22. PubMed ID: 10503801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.
    Matsouaka RA; Betensky RA
    Stat Med; 2015 Feb; 34(3):406-31. PubMed ID: 25393385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric test of stochastic ordering for multiple longitudinal measures.
    Rosenberger WF; Lachin JM; Bain RP
    J Biopharm Stat; 1995 Nov; 5(3):235-43. PubMed ID: 8580926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential monitoring of survival data with the Wilcoxon statistic.
    Lan KK; Rosenberger WF; Lachin JM
    Biometrics; 1995 Sep; 51(3):1175-83. PubMed ID: 7548701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of phase II trials in congestive heart failure.
    DeMets DL
    Am Heart J; 2000 Apr; 139(4):S207-10. PubMed ID: 10740134
    [No Abstract]   [Full Text] [Related]  

  • 6. Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches.
    Miller ME; Morgan TM; Espeland MA; Emerson SS
    Stat Med; 2001 Aug; 20(16):2383-97. PubMed ID: 11512129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Hood WB; Dans A; Guyatt GH; Jaeschke R; McMurray JV
    Cochrane Database Syst Rev; 2001; (3):CD002901. PubMed ID: 11687032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Hood WB; Dans A; Guyatt GH; Jaeschke R; McMurray J
    Cochrane Database Syst Rev; 2001; (1):CD002901. PubMed ID: 11279775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
    DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
    J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
    Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP
    N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?
    Mukaka M; White SA; Terlouw DJ; Mwapasa V; Kalilani-Phiri L; Faragher EB
    Trials; 2016 Jul; 17():341. PubMed ID: 27450066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fallacies of last observation carried forward analyses.
    Lachin JM
    Clin Trials; 2016 Apr; 13(2):161-8. PubMed ID: 26400875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    Feldman AM; Baughman KL; Lee WK; Gottlieb SH; Weiss JL; Becker LC; Strobeck JE
    Am J Cardiol; 1991 Nov; 68(11):1203-10. PubMed ID: 1951080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.
    Hidalgo R; Martí-Carvajal AJ; Kwong JS; Simancas-Racines D; Nicola S
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009077. PubMed ID: 23152267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using exercise endpoints in heart failure trials: design considerations.
    Yusuf S; Tsuyuki R
    Eur Heart J; 1996 Jan; 17(1):4-6. PubMed ID: 8682129
    [No Abstract]   [Full Text] [Related]  

  • 17. Handling of Missing Outcome Data in Acute Stroke Trials: Advantages of Multiple Imputation Using Baseline and Postbaseline Variables.
    Young-Saver DF; Gornbein J; Starkman S; Saver JL
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3662-3669. PubMed ID: 30297167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies.
    Reis SE; Holubkov R; Young JB; White BG; Cohn JN; Feldman AM
    J Am Coll Cardiol; 2000 Aug; 36(2):529-33. PubMed ID: 10933368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
    Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
    BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worst-Rank Score Methods-A Nonparametric Approach to Informatively Missing Data.
    Lachin JM
    JAMA; 2020 Oct; 324(16):1670-1671. PubMed ID: 32986071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.